water through a cloth filter or pipe filters to remove copepods (small crustaceans that host D. medinensis larvae); 3) treating potentially contaminated surface water with the organophosphate insecticide temephos (Abate) to kill the copepods; and 4) providing safe drinking water from bore-hole or protected hand-dug wells (5) . Containment † of transmission is achieved through four complementary measures: 1) voluntary isolation and education of each patient to prevent contamination of drinking water sources, 2) provision of first aid to prevent secondary infections, 3) manual extraction of the worm, and 4) application of occlusive bandages. No vaccine or medicine to prevent or treat Guinea worm disease currently exists.
D. medinensis has an approximately 1-year incubation period (range = 10-14 months) after infection (5) . A case of dracunculiasis is defined as an infection occurring in a person exhibiting a skin lesion or lesions with emergence of one or more worms that are laboratory-confirmed at CDC as D. medinensis. Each infected person is counted as a case only once during a calendar year. Because certain patients have multiple Guinea worms emerge, more laboratory-confirmed specimens than cases might be reported in any given period.
Countries enter the WHO precertification stage of eradication after 1 full year with no reported indigenous § cases. An imported case is an infection resulting from ingestion of contaminated water from a source, identified through patient interviews and epidemiologic investigation, in a place other than in the community where the patient is detected and the case reported (i.e., another country or village within the same country). Since 2012, no known internationally imported cases have been reported. † Transmission from a patient with dracunculiasis is contained only if all of the following conditions are met for each emerged worm: 1) the infected patient is identified ≤24 hours after worm emergence; 2) the patient has not entered any water source because the worm emerged; 3) a village volunteer or other health care provider has managed the patient properly, by cleaning and bandaging the lesion until the worm has been fully removed manually and by providing health education to discourage the patient from contaminating any water source (if two or more emerging worms are present, transmission is not contained until the last worm is removed); 4) the containment process, including verification of dracunculiasis, is validated by a Guinea Worm Eradication Program supervisor within 7 days of emergence of the worm; and 5) temephos is used to treat potentially contaminated surface water if any uncertainty about contamination of these sources of drinking water exists, or if such a source of drinking water is known to have been contaminated. § An indigenous case of dracunculiasis is defined as an infection consisting of a skin lesion or lesions with emergence of one or more Guinea worms in a person who had no history of travel outside their residential locality during the preceding year. In each affected country, a national dracunculiasis eradication program receives monthly reports regarding cases from each village under active surveillance. Reporting rates are calculated as the proportion of all villages under active surveillance reporting monthly ( Table 2 ). Active surveillance is conducted in all villages with endemic dracunculiasis or that are at high risk for importation, with daily searches of households for persons with signs or symptoms of dracunculiasis, to ensure case detection within 24 hours of worm emergence and prompt patient management to prevent contamination of water sources. Villages where endemic transmission of dracunculiasis is interrupted (i.e., zero cases reported for ≥12 consecutive months) are kept under active surveillance for 3 consecutive years. WHO certifies a country free from dracunculiasis after that country maintains adequate nationwide surveillance for ≥3 consecutive years and demonstrates that no indigenous cases occurred during that period. As of January 2016, WHO had certified 198 countries, areas, and territories as free from dracunculiasis (3). Eight countries remain to be certified: four where dracunculiasis is currently endemic (Chad, Ethiopia, Mali, and South Sudan), two in the precertification stage (Kenya and Sudan), and two never known to have had endemic dracunculiasis since the global eradication program began in 1980 (Angola and the Democratic Republic of the Congo), which are in the process of completing the requirements for certification.
During January 2016-June 2017, CDC evaluated 118 worm specimens that emerged from humans, including 108 (91.5%) from the four countries with endemic dracunculiasis, two (1.7%) from Kenya, three (2.5%) from Benin (Kenya and Benin formerly had endemic dracunculiasis), four (3.4%) from the Democratic Republic of Congo, and one (1%) from Niger. Among the 118 human worm specimens submitted, 89 (75%) were from 2016 (37 [42%] were identified as D. medinensis) and 29 were from January to June 2017 (eight [28%] were identified as D. medinensis).
During 2016, 46 animal worm specimens were submitted, and 32 (70%) were identified as D. medinensis. The 32 Dracunculus specimens came from two baboons and 13 dogs from Ethiopia, 11 dogs from Mali, and five dogs and one domestic cat from Chad. During January-June 2017, 18 animal worm specimens were submitted and 14 were identified as D. medinensis. The 114 Dracunculus specimens came from four baboons and nine dogs from Ethiopia, and one dog from Chad.
Country Reports
Chad. After a decade with no reported cases, Chad reported 10 indigenous cases in 2010. After indigenous cases were confirmed during 3 consecutive years, dracunculiasis was declared to be endemic in 2012 (6, 7) . In 2016, Chad reported 16 cases (nine contained) in 12 villages, compared with nine cases (none contained) in 2015. During the first half of 2017, eight cases (six contained) were reported in eight villages. One of 12 villages that reported a case in 2016, and one of eight reporting a case during January-June 2017, had reported a case previously.
In 2012, Guinea worm infections were first reported in domestic dogs in Chad (6), and since then, more dogs than humans have been identified with emerging Guinea worms. This substantial number of nonhuman infections has not occurred in any other country during the eradication campaign. Worm specimens obtained from dogs were determined to be genetically indistinguishable from D. medinensis worms removed from humans in Chad (6) . A majority of infections during the current outbreak have occurred in communities along the Chari River. The Carter Center has assisted the ministry of health in implementing active village-based surveillance for the disease in approximately 1,700 villages in the at-risk zone. The working hypothesis, on the basis of biologic, environmental, and epidemiologic investigations by CDC and the Carter Center, is that the cases in humans and infected dogs are associated with the domestic and commercial fishing industry along the Chari River and involve fish, frogs, or other aquatic hosts that serve as paratenic hosts (intermediate hosts in which no development of the parasite occurs). New infections are thought to occur when humans consume inadequately cooked paratenic hosts and when such hosts are * Participants at the annual Chad Guinea Worm Eradication Program review meeting in November 2014 adopted "1+ case village" as a new description for villages in Chad affected by human cases of Guinea worm disease or dogs infected with Guinea worms and defined as "a village with one or more indigenous or imported cases of Guinea worm infections in humans, dogs, or cats in the current calendar year or previous year. " † Civil unrest and insecurity continued to constrain Guinea Worm Eradication Program operations (supervision, surveillance, and interventions in Gao, Kidal, and Timbuktu regions). § Imported from another country. ¶ Transmission from a patient with dracunculiasis is contained only if all of the following conditions are met for each emerged worm: 1) the infected patient is identified ≤24 hours after worm emergence; 2) the patient has not entered any water source because the worm emerged; 3) a village volunteer or other health care provider has managed the patient properly, by cleaning and bandaging the lesion until the worm has been fully removed manually and by providing health education to discourage the patient from contaminating any water source (if two or more emerging worms are present, transmission is not contained until the last worm is removed); 4) the containment process, including verification of dracunculiasis, is validated by a Guinea Worm Eradication Program supervisor within 7 days of emergence of the worm; and 5) temephos is used to treat potentially contaminated surface water if any uncertainty about contamination of these sources of drinking water exists, or if a such a source of drinking water is known to have been contaminated. ** Imported from another in-country village with endemic disease.
† † The denominator is the number of endemic villages/localities where the program applied interventions during 2015-2016.
consumed raw by dogs (6). Overall, 1,011 infected dogs (and 11 infected domestic cats) were reported during 2016, which was twice the number of infected dogs (503) reported in 2015. However, during January-June 2017, 537 infected dogs were reported, which is an 18% decrease from the 653 reported during the same period of 2016. This is the first such half-yearly reduction since infected dogs were first reported in 2012, and it reflects consecutive months of declining dog infections that began in November 2016 (3). Beginning in October 2013, Chad's Guinea Worm Eradication Program urged villagers to cook their fish well, bury fish entrails, and prevent dogs from eating fish entrails. By June 2017, according to monthly sample surveys, this intervention was being implemented by approximately 81% of respondents in surveyed communities with populations at risk. In February 2014, health education measures began to persuade villagers to tether infected dogs until the worms emerged, to prevent contamination of water and infection of copepods. In February 2015, the program introduced a reward equivalent to US$20 for reporting and tethering an infected dog. Whereas 40%, 68%, and 68% of infected dogs were tethered in 2014, 2015, and 2016, respectively, 78% of 537 infected dogs reported during January-June 2017 were tethered.
Beginning before 2010, Chad has offered a cash reward equivalent to US$100 for reporting a human case of dracunculiasis. In areas under active surveillance, 69% of 383 residents surveyed during January-June 2017 knew of the cash reward for reporting a case of dracunculiasis, and 60% of 363 persons surveyed knew of the cash reward for reporting and tethering an infected dog.
As of June 2017, 68% of villages with endemic dracunculiasis had safe water (i.e., water sources free of copepods, such as rapidly flowing rivers, protected hand dug wells, and borehole wells). Temephos use is limited by the extremely large lagoons used for fishing and as sources of drinking water. Starting in August 2014, an innovative technique of applying temephos to smaller cordoned sections of the lagoons at entry points used by infected humans or dogs was introduced and used to protect 19, 29, 61, and 51 villages in 2014, 2015, 2016, and January-June 2017, respectively.
The Carter Center and WHO Collaborating Center for Dracunculiasis Eradication at CDC are supporting research to better understand the unusual epidemiology of the current outbreak of dracunculiasis in Chad, assess antihelminthic treatment of dogs to prevent maturation of worms, and study the food sources and movements of dogs in an area of Chad with endemic disease. In collaboration with researchers from the University of Georgia, this initiative has demonstrated that D. medinensis can use an amphibian (frog) (8) as a paratenic host in the laboratory (8) and has recovered, for the first time, a Dracunculus larva from a frog captured in the wild in Chad (9) .
Ethiopia. In 2016, Ethiopia reported three cases of dracunculiasis (two contained), in two villages of the Gog district and one village of the Lare district of Gambella Region. This is the same number of cases that Ethiopia reported in 2015 and in 2014. (The origin of the third case, which was reported in September 2016, is unclear, because the patient entered Ethiopia from South Sudan approximately 1 year before emergence of his Guinea worm). Ethiopia also reported 14 infected domestic dogs and two infected baboons in 2016, compared with 13 infected dogs and one infected baboon in 2015, all in the same area of the Gog district. During January-June 2017, Ethiopia reported no human case, eight infected dogs, and four infected baboons. However, in the same area of the Gog district, there were two cases in humans, two infected dogs, and no infected baboons during the same period of 2016. The program applied temephos monthly to almost all water sources known to have been used by humans in the at-risk area throughout 2015, increased coverage threefold to include numerous smaller water sources in 2016, and is addressing additional gaps in identification of water sources related to a particular stream in the at-risk area in 2017. A cash reward, equivalent to US$20 for reporting an infected animal was introduced, and the ministry of health held three press conferences to publicize the eradication effort during 2016. There are 152 villages under active surveillance in three districts of Gambella Region. Ethiopia offers a cash reward equivalent to US$100 for reporting a case of dracunculiasis. Among 11,712 persons surveyed in the Gog district during January-June 2017, 82% were aware of the reward for reporting an infected person; 61% of 2,123 surveyed knew of the reward for reporting an infected animal.
Mali. In 2016, Mali reported no human cases of dracunculiasis for the first time since its eradication program began, compared with five cases reported from three villages in 2015. What are the implications for public health practice?
Although earlier target dates for global dracunculiasis eradication were missed, progress towards this goal has accelerated. However, rigorous implementation (including recent interventions to prevent transmission to and from dogs) must be maintained in Chad to ensure continued progress during 2017 and beyond. Additional interventions, including increased use of temephos and trials of potential anthelminthic treatments for infected dogs are beginning or underway in Chad. In addition, scientists are researching aspects of the parasite's biology, life cycle, and molecular composition, and dog ecology. Furthermore, a case-control study of humans and dogs in households with and without infected dogs is planned in Chad for early 2018.
